Kukje Pharma Co (XKRX:002720) Ending Cash Position : ₩9,918 Mil (As of Mar. 2025)

View and export this data going back to 1975. Start your Free Trial

What is Kukje Pharma Co Ending Cash Position?

Kukje Pharma Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩9,918 Mil.

Kukje Pharma Co's quarterly Ending Cash Position increased from Sep. 2024 (₩8,583 Mil) to Dec. 2024 (₩8,678 Mil) and increased from Dec. 2024 (₩8,678 Mil) to Mar. 2025 (₩9,918 Mil).

Kukje Pharma Co's annual Ending Cash Position increased from Dec. 2022 (₩5,539 Mil) to Dec. 2023 (₩10,590 Mil) but then declined from Dec. 2023 (₩10,590 Mil) to Dec. 2024 (₩8,678 Mil).

Kukje Pharma Co Ending Cash Position Historical Data

The historical data trend for Kukje Pharma Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kukje Pharma Co Ending Cash Position Chart

Kukje Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

4,013.02

7,866.06

5,538.93

10,589.87

8,678.41

Kukje Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															12,743.92	6,825.42	8,582.84	8,678.41	9,918.50

Kukje Pharma Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kukje Pharma Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10589.867	+	-1911.461
	=	8,678

Kukje Pharma Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8678.406	+	1240.09
	=	9,918

Kukje Pharma Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kukje Pharma Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kukje Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kukje Pharma Co Ltd (XKRX:002720) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

96-8 Yatapiro, Bundang-Gu, Seongnam-si, Gyeonggi, KOR, 463-839

Website

http://www.kukjepharm.co.kr

Kukje Pharma Co Ltd engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products internationally. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antifungal and antiviral agents, and other antibiotics.

Kukje Pharma Co Headlines

No Headlines